TranS1 (BAXSQ) Stock Price, News & Analysis

Company Overview

TranS1 Inc. was a medical device company focused on developing minimally invasive technologies for spinal surgery. Its products were designed to support lumbar fusion and decompression procedures while reducing the tissue disruption associated with conventional open surgery.

The company’s best-known product was the AxiaLIF system, a presacral access and interbody fusion system intended for certain lower-spine procedures. TranS1 also developed the iO-Flex system, which was designed to help surgeons decompress spinal nerves through a minimally invasive approach. Its products were marketed primarily to spine surgeons and hospitals in the United States.

TranS1 later became known as Baxano Surgical following a corporate transaction and expanded its focus on minimally invasive spine technologies. The company subsequently encountered significant financial and operating difficulties and pursued bankruptcy-related proceedings. Because the business is historical and information about its later operations and leadership is limited, current product, management and geographic details may not be available.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Surgical, Medical, And Dental Instruments And Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:BAXSQ
• Previous Symbol: NASDAQ:BAXS
• CIK: N/A
• Web: baxanosurgical.com
• Phone: +1-919-8000020
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A